Jacob Giordano
Cardiovascular Disease · Columbia, SCNPI 1659938504
Payments from drug & device makers
Across 83 payments — averaging $57.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$2K
- Medtronic$584
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$474
- Teleflex LLC$309
- Abiomed$307
- Boehringer Ingelheim$285
- plus $1K from 18 others
What the payments were for
- Travel & lodging$2,02442%
- Food & beverage$2,76358%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 11 | $1,740 |
| Medtronic | 3 | $584 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 23 | $474 |
| Teleflex LLC | 3 | $309 |
| Abiomed | 8 | $307 |
| Boehringer Ingelheim | 5 | $285 |
| Boston Scientific | 2 | $230 |
| Lexicon Pharmaceuticals, Inc. | 1 | $125 |
| Impulse Dynamics (USA) Inc. | 1 | $110 |
| Pfizer | 1 | $100 |
| E.r. Squibb & Sons, L.L.C. | 4 | $70 |
| Atricure, Inc. | 2 | $63 |
| Amgen | 3 | $53 |
| Philips North America LLC | 2 | $48 |
| Novo Nordisk | 2 | $45 |
| Cardiva Medical, Inc. | 2 | $45 |
| Actelion Pharmaceuticals US, Inc. | 2 | $43 |
| Novartis | 2 | $30 |
| Kestra Medical Technology Services, Inc. | 1 | $24 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $23 |
| Bayer | 1 | $23 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,787 in reported general payments places this provider in the 55th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 43 | $27,506 |
| EntrestoSacubitril/Valsartan | 17 | $22,366 |
| JardianceEmpagliflozin | 15 | $10,081 |
| Metoprolol Succinate | 51 | $514 |
| Atorvastatin Calcium | 22 | $265 |
| Losartan Potassium | 12 | $96 |
| Lisinopril | 14 | $92 |
| ClopidogrelClopidogrel Bisulfate | 13 | $92 |
| Amlodipine Besylate | 43 | $78 |
| Metoprolol Tartrate | 17 | $48 |
| Hydralazine Hcl | 12 | $25 |
| Spironolactone | 12 | $4 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $100 | $27,50643 claims |
| NovartisEntresto | $30 | $22,36617 claims |
| Boehringer IngelheimJardiance | $285 | $10,08115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 257 cardiovascular disease providers in South Carolina.
Other cardiovascular disease in Columbia
- Ryan MacnevinColumbia$67K
- Lauren HollidayColumbia$14K
- Meghan BusinaroColumbia$11K
- Brent McLaurinAnderson$1.1M
- Robert BiedermanCharleston$801K
- James MerriamGreenville$728K
- Vipul ShahLancaster$488K
- Arthur EberlyGreenville$438K
- Gregory SanGreenville$429K
- Naresh MoriRock Hill$408K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.